BIOPSY-PROVEN DIABETIC NEPHROPATHY WORSENS RENAL PROGNOSIS IN DIABETIC PATIENT: RESULTS MULTICENTER STUDY BIODIAB-GLOSEN-GEENDIAB

被引：0

作者：

Bermejo, Sheila ^{[1
]}

Gonzalez, Ester ^{[2
]}

Martin, Nadia ^{[3
]}

Garcia, Rosa ^{[4
]}

Linares, Tania ^{[5
]}

Poch, Esteban ^{[6
]}

Esparza, Noemi ^{[7
]}

Diaz-Encarnacion, Montserrat ^{[8
]}

Irene, Agraz ^{[9
]}

Isabel Navarro, Maruja ^{[9
]}

Lopez, Katia ^{[10
]}

Ibernon, Meritxell ^{[11
]}

Garcia, Nuria ^{[12
]}

Lopez, Diana ^{[12
]}

Martin-Gomez, Adoracion ^{[13
]}

Praga, Manuel ^{[2
]}

Galceran, Josep Ma ^{[1
]}

Pascual, Julio ^{[14
]}

Fulladosa, Xavier ^{[15
]}

Soler Romeo, Maria Jose ^{[16
]}

机构：

[1] Xarxa Assistencial Univ Manresa, Althaia, Manresa, Spain

[2] Hosp Univ 12 Octubre, Madrid, Spain

[3] Hosp Univ Girona Doctor Josep Trueta, Girona, Spain

[4] Hosp Palamos, Palamos, Spain

[5] Gregorio Maranon Hosp, Madrid, Spain

[6] Hosp Clin Barcelona, Barcelona, Spain

[7] Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain

[8] Puigvert Hosp, Barcelona, Spain

[9] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[10] Fdn Hosp Alcorcon, Alcorcon, Spain

[11] Hosp St Joan Desp Moises Broggi, St Joan Despi, Spain

[12] Clin Univ Navarra, Pamplona, Spain

[13] Hosp Poniente, Almeria, Spain

[14] Hosp del Mar, Barcelona, Spain

[15] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain

[16] Hosp Univ Vall dHebron, Hosp del Mar, Pi17-00257 Redinren, Barcelona, Spain

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

SaO011

引用

页数：2

共 50 条

[31] Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
Okada, Sadanori
Samejima, Ken-ichi
Matsui, Masaru
Morimoto, Katsuhiko
Furuyama, Riri
Tanabe, Kaori
Eriguchi, Masahiro
Akai, Yasuhiro
Saito, Yoshihiko
Tsuruya, Kazuhiko
[J]. BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
[32] Utility of serum β2-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathy
Uemura, Takayuki
Nishimoto, Masatoshi
Eriguchi, Masahiro
Tamaki, Hiroyuki
Tasaki, Hikari
Furuyama, Riri
Fukata, Fumihiro
Kosugi, Takaaki
Morimoto, Katsuhiko
Matsui, Masaru
Samejima, Ken-ichi
Tsuruya, Kazuhiko
[J]. DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 583 - 591
[33] Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls
Tao, Sibei
Zheng, Wen
Liu, Yuan
Li, Ling
Li, Lingzhi
Ren, Qian
Shi, Min
Liu, Jing
Jiang, Jing
Ma, Huichao
Huang, Zhuo
Xia, Zijing
Pan, Jing
Wei, Tiantian
Wang, Yan
Li, Peiyun
Lan, Tian
Ma, Liang
Fu, Ping
[J]. RSC ADVANCES, 2019, 9 (33) : 18713 - 18719
[34] Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease
Lee, Yu Ho
Seo, Jung-Woo
Kim, Miji
Tae, Donghyun
Seok, Junhee
Kim, Yang Gyun
Lee, Sang-Ho
Kim, Jin Sug
Hwang, Hyeon Seok
Jeong, Kyung-Hwan
Moon, Ju-Young
[J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
[35] The effect of non-albumin proteinuria on renal outcomes in patients with biopsy proven diabetic nephropathy
Kazan, S.
Tunca, O.
[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (21) : 7892 - 7898
[36] STUDY INTO RENAL PROGNOSIS BY HISTOPATHOLOGICAL FINDINGS ON PATIENTS WITH DIABETIC NEPHROPATHY
Eiichi, Sato
Mayuko, Amaha
Mayumi, Nomura
Daisuke, Matsumura
Akiko, Fujii
Hidetsugu, Yamagishi
Yuko, Ono
Tsukasa, Nakamura
Yoshihiko, Ueda
[J]. NEPHROLOGY, 2014, 19 : 134 - 134
[37] The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration
Albrecht, Thomas
Zhang, Shiqi
Braun, Jana D.
Xia, Li
Rodriquez, Angelica
Qiu, Jiedong
Peters, Verena
Schmitt, Claus P.
van den Born, Jacob
Bakker, Stephan J. L.
Lammert, Alexander
Koeppel, Hannes
Schnuelle, Peter
Kraemer, Bernhard K.
Yard, Benito A.
Hauske, Sibylle J.
[J]. JOURNAL OF DIABETES RESEARCH, 2017, 2017
[38] Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy
Wu, Chung-Ze
Chang, Li-Chien
Lin, Yuh-Feng
Hung, Yi-Jen
Pei, Dee
Chu, Nain-Feng
Chen, Jin-Shuen
[J]. CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1324 - 1329
[39] Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy
Miho Shimizu
Kengo Furuichi
Shinji Kitajima
Tadashi Toyama
Megumi Oshima
Hisayuki Ogura
Koichi Sato
Shiori Nakagawa
Yuta Yamamura
Taro Miyagawa
Akinori Hara
Yasunori Iwata
Norihiko Sakai
Kiyoki Kitagawa
Mitsuhiro Yoshimura
Hitoshi Yokoyama
Takashi Wada
[J]. BMC Nephrology, 22
[40] Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study
Shimizu, Miho
Furuichi, Kengo
Toyama, Tadashi
Yamanouchi, Masayuki
Hoshino, Junichi
Kitajima, Shinji
Hara, Akinori
Iwata, Yasunori
Sakai, Norihiko
Yuzawa, Yukio
Kitamura, Hiroshi
Sato, Hiroshi
Shibagaki, Yugo
Suzuki, Yoshiki
Uesugi, Noriko
Ueda, Yoshihiko
Kohagura, Kentaro
Samejima, Kenichi
Tsuruya, Kazuhiko
Nishi, Shinichi
Nishino, Tomoya
Makino, Hirofumi
Matsuo, Seiichi
Ubara, Yoshifumi
Yokoyama, Hitoshi
Wada, Takashi
[J]. JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (11) : 1268 - 1278

← 1 2 3 4 5 →